Wells, A.U. and Hirani, N. (2008) Interstitial Lung Disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax, 63, v1-v58.
http://dx.doi.org/10.1136/thx.2008.101691

has been cited by the following article:

• TITLE: Secondary Bacterial Organizing Pneumonia in a Patient Recovered from COVID-19 Disease: A Case Report

  AUTHORS: Alaa Al Zaki, Reem Al Argan, Abir Al Said, Fears Al Kuwaiti

  KEYWORDS: COVID-19 Disease, Organizing Pneumonia, Secondary Bacterial Infection, Bronchoalveolar Lavage, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.10 No.2, February 25, 2021

  ABSTRACT: COVID-19 disease is a global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) that mainly presents with pneumonia, but has variable multi-systemic manifestations. Concomitant bacterial infections associated with the acute stage of COVID-19 disease have been rarely reported in the literature. However, to our knowledge, post viral organizing pneumonia (OP) secondary to bacterial infection after recovery from SARS-CoV2 infection has not been noted before. We report a 27-year-old male patient with Type 1 Diabetes Mellitus who presented with fever post recovery from COVID-19 disease for seven weeks and was found to have OP secondary to Klebsiella pneumoniae. Furthermore, the bronchoalveolar lavage was positive for SARS-CoV2 by RT-PCR despite multiple negative nasopharyngeal RT-PCR. The patient was successfully treated with antibiotics only. Therefore, we conclude that early recognition of OP secondary to bacterial infection in patients with COVID-19 disease and prompt antibiotic treatment could avoid the use of a prolonged course of steroids.